Derma Sciences
Derma Sciences engages in the development and commercialization of novel proprietary regenerative products for the treatment of chronic and acute wounds.
Business Model:
Revenue: $84.5M
Employees: 201-500
Rankings
Industries / Tags:
Detailed Derma Sciences Information
Derma Sciences was acquired by
Integra LifeSciences.
The acquisition happend on 2017-01-10.
Details of the transaction were not public
Acquirer
Geographic Data
Address: 311 Enterprise Dr
City: Plainsboro
State: NJ
Zip: 08536
Country: US
Financial Info
Stage:
post ipo equity
Raised Last:
$29M
Raised Total:$29M
Social
Metrics
0Website Global Rank
0Website Monthly Traffic
Twitter Followers
Description
Derma Sciences engages in the development and commercialization of novel proprietary regenerative products for the treatment of chronic and acute wounds.
Contact Phone:
+16095144744
Contact Email:
Derma Sciences went public on 2/19/2010 on the NASDAQ
Listed Exchange:
NASDAQ
IPO Date:
2/19/2010
Ticker Symbol:
DSCI
Amount Raised:
$86M
Live
Opened: -/share
| EBITDA | - |
| Total Cash | - |
| Total Debt | - |
| Total Revenue | - |
| Total Profit (Gross) | - |
| PE Ratio | - |
| Announced Date | Company | Transaction | Money Raised |
|---|
| Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 6/2011 | Equity | $29.1M | 5/1994 | IPO | - | 4/2012 | Secondary Offering | $19.7M | 7/2011 | Post-IPO Equity | $29.1M | 5/1994 | IPO | - |
|---|
| Announced Date | Name | Price |
|---|---|---|
| 7/2016 | BioD |
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
